Search the Newsreel

BlackRock (PRVA holder) discloses 14.2% ownership in Privia Health Group on 13G/A

BlackRock, Inc. has filed an amended Schedule 13G disclosing a beneficial ownership of 17,929,937 shares of Privia Health Group, Inc. common stock, which represents 14.2% of the class. The filing indicates BlackRock holds sole voting power over 17,744,673 shares and sole dispositive power over …

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a Potential 29% Upside with Solid Revenue Growth

Privia Health Group Inc (PRVA) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Privia Health Group Inc (PRVA), highlighting its robust financial status and high operating efficiency. The company holds a current financial score of 7.59, ranking 36 out of 75 in the Healthcare Providers & Services industry. It …

PRVA|Privia Health Group Inc|Price:25.500|Chg%:+0.530

Privia Health Group Inc (PRVA) is a technology-driven physician-enablement company focused on enhancing physician practices and patient experiences through its Privia Platform. The company reported a market cap of $3.13 billion and a P/E TTM of 143.83. Key executives and shareholdings are detailed, alongside …

Privia Health Group Inc (PRVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article details Privia Health Group Inc.'s (PRVA) revenue breakdown by business segment. As of the latest update, FFS-patient care constitutes the largest portion of revenue at 64.08%, followed by capitated revenue and shared savings. The company has not yet disclosed regional revenue or …

3 Reasons to Avoid PRVA and 1 Stock to Buy Instead

3 Reasons to Avoid PRVA and 1 Stock to Buy Instead Since January 2026, Privia Health has been in a holding pattern, posting a small return of 3.6% while floating around $24.97. Is now the time to buy Privia Health, or should you be …

Citi Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35

Citi has reiterated its Buy rating for Privia Health (PRVA.US) and increased the target price to $35. This update from Citi indicates a positive outlook on the company's financial prospects and stock performance.

(PRVA) Movement as an Input in Quant Signal Sets

The article analyzes Privia Health Group Inc. (NASDAQ: PRVA), noting conflicting sentiment and a mid-channel oscillation pattern. It highlights an exceptional 31.9:1 risk-reward short setup targeting 9.5% downside. Three distinct AI-generated trading strategies are presented for different risk profiles: a Position Trading Strategy, a …

Privia Health sets Aug. 6 earnings call and outlook update

Privia Health Group (PRVA) Stock Could Be 24.7% Undervalued After Strong Growth

What Privia Health Group (PRVA)'s New Jersey Neurology Anchor Deal Means For Shareholders

How The Privia Health Group (PRVA) Narrative Is Shifting With Mixed Targets And New Deals

Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point

Privia Health (PRVA) Misses Q1 Earnings Estimates

Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings?